Evaluation of microbial bacterial and fungal diversity in cerebrospinal fluid shunt infection

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Simon, Tamara D ^a,b   Pope, Christopher E ^a   Browd, Samuel R ^c   Ojemann, Jeffrey G ^c   Riva Cambrin, Jay ^d   Mayer Hamblett, Nicole ^a,b   Rosenfeld, Margaret ^a,b   Zerr, Danielle M ^a,b   Hoffman, Lucas ^a,b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; INTERNAL TRANSCRIBED SPACER; RNA 16S;

16S RRNA GENE; ACREMONIUM; ADOLESCENT; ARTICLE; ASPERGILLUS; AUREOBASIDIUM; BACTERIUM IDENTIFICATION; CEREBROSPINAL FLUID SHUNT INFECTION; CEREBROSPINAL FLUID SHUNTING; CHILD; CLADOSPORIUM; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS; DEBARYOMYCES HANSENII; DNA EXTRACTION; FUNGUS IDENTIFICATION; GENE AMPLIFICATION; HIGH THROUGHPUT SEQUENCING; HUMAN; MALASSEZIA; MALASSEZIA PACHYDERMATIS; MALASSEZIA SYMPODIALIS; MICROBIAL DIVERSITY; MICROFLORA; NUCLEOTIDE SEQUENCE; PHYLOGENY; PSEUDOMONAS AERUGINOSA; PYROSEQUENCING; RHODOTORULA MUCILAGINOSA; SCHIZOPHYLLUM COMMUNE; SHUNT INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS LUGDUNENSIS; TAXON;

BACTERIA; CEREBROSPINAL FLUID SHUNTS; COMMUNICABLE DISEASES; FUNGI; GENETIC VARIATION; HUMANS; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 84897468336     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083229     Document Type: Article

References (32)

1. Kestle JR (2003) Pediatric hydrocephalus: current management. Neurol Clin 21: 883-895, vii.
2. Simon TD, Riva-Cambrin J, Srivastava R, Bratton SL, Dean JM, et al. (2008) Hospital care for children with hydrocephalus in the United States: utilization, charges, comorbidities, and deaths. J Neurosurg Pediatrics 1: 131-137. (Pubitemid 351396969)
3. Odio C, McCracken GH Jr, Nelson JD (1984) CSF shunt infections in pediatrics. A seven-year experience. Am J Dis Child 138: 1103-1108. (Pubitemid 15210442)
4. Nelson JD (1984) Cerebrospinal fluid shunt infections. Pediatr Infect Dis 3: S30-32.
5. Sells CJ, Shurtleff DB, Loeser JD (1977) Gram-negative cerebrospinal fluid shunt-associated infections. Pediatrics 59: 614-618. (Pubitemid 8092817)
6. Fan-Havard P, Nahata MC (1987) Treatment and prevention of infections of cerebrospinal fluid shunts. Clin Pharm 6: 866-880. (Pubitemid 17162996)
7. Chiou CC, Wong TT, Lin HH, Hwang B, Tang RB, et al. (1994) Fungal infection of ventriculoperitoneal shunts in children. Clin Infect Dis 19: 1049-1053. (Pubitemid 24380017)
8. Kestle JR, Garton HJ, Whitehead WE, Drake JM, Kulkarni AV, et al. (2006) Management of shunt infections: a multicenter pilot study. J Neurosurg 105: 177-181. (Pubitemid 44968407)
9. Vinchon M, Dhellemmes P (2006) Cerebrospinal fluid shunt infection: risk factors and long-term follow-up. Childs Nerv Syst 22: 692-697. (Pubitemid 43933691)
10. Younger JJ, Christensen GD, Bartley DL, Simmons JC, Barrett FF (1987) Coagulase-negative staphylococci isolated from cerebrospinal fluid shunts: importance of slime production, species identification, and shunt removal to clinical outcome. J Infect Dis 156: 548-554. (Pubitemid 17154662)
11. Walters BC, Hoffman HJ, Hendrick EB, Humphreys RP (1984) Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 60: 1014-1021. (Pubitemid 14134808)
12. Kanev PM, Sheehan JM (2003) Reflections on shunt infection. Pediatr Neurosurg 39: 285-290. (Pubitemid 38134829)
13. Gardner P, Leipzig T, Phillips P (1985) Infections of central nervous system shunts. Med Clin North Am 69: 297-314. (Pubitemid 15042675)
14. Gardner P, Leipzig TJ, Sadigh M (1988) Infections of mechanical cerebrospinal fluid shunts. Curr Clin Top Infect Dis 9: 185-214.
15. Morissette I, Gourdeau M, Francoeur J (1993) CSF shunt infections: a fifteen-year experience with emphasis on management and outcome. Can J Neurol Sci 20: 118-122. (Pubitemid 23212862)
16. Venes JL (1989) Infections of CSF shunt and intracranial pressure monitoring devices. Infect Dis Clin North Am 3: 289-299.
17. Williams MA, McAllister JP, Walker ML, Kranz DA, Bergsneider M, et al. (2007) Priorities for hydrocephalus research: report from a National Institutes of Health-sponsored workshop. Journal of Neurosurgery (5 Suppl Pediatrics): 345-357.
18. Kulkarni AV, Rabin D, Lamberti-Pasculli M, Drake JM (2001) Repeat cerebrospinal fluid shunt infection in children. Pediatr Neurosurg 35: 66-71. (Pubitemid 32830623)
19. Tuan TJ, Thorell EA, Hamblett NM, Kestle JR, Rosenfeld M, et al. (2011) Treatment and microbiology of repeated cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 30: 731-735.
20. Fux CA, Quigley M, Worel AM, Post C, Zimmerli S, et al. (2006) Biofilm-related infections of cerebrospinal fluid shunts. Clin Microbiol Infect 12: 331-337. (Pubitemid 43337522)
21. Guevara JA, Zuccaro G, Trevisan A, Denoya CD (1987) Bacterial adhesion to cerebrospinal fluid shunts. J Neurosurg 67: 438-445. (Pubitemid 17128362)
22. Bayston R, Ullas G, Ashraf W (2012) Action of linezolid or vancomycin on biofilms in ventriculoperitoneal shunts in vitro. Antimicrob Agents Chemother 56: 2842-2845.
23. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-1322. (Pubitemid 29289651)
24. Rhoads DD, Wolcott RD, Sun Y, Dowd SE (2012) Comparison of culture and molecular identification of bacteria in chronic wounds. Int J Mol Sci 13: 2535-2550.
25. Rickard AH, Gilbert P, High NJ, Kolenbrander PE, Handley PS (2003) Bacterial coaggregation: an integral process in the development of multi-species biofilms. Trends Microbiol 11: 94-100. (Pubitemid 36207506)
26. Falkow S (1988) Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis 10 Suppl 2: S274-276.
27. Kuramitsu HK, He X, Lux R, Anderson MH, Shi W (2007) Interspecies interactions within oral microbial communities. Microbiol Mol Biol Rev 71: 653-670. (Pubitemid 350309182)
28. Espy MJ, Uhl JR, Sloan LM, Buckwalter SP, Jones MF, et al. (2006) Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev 19: 165-256. (Pubitemid 43158452)
29. Han A, Zenilman JM, Melendez JH, Shirtliff ME, Agostinho A, et al. (2011) The importance of a multifaceted approach to characterizing the microbial flora of chronic wounds. Wound Repair Regen 19: 532-541.
30. Seng P, Rolain JM, Fournier PE, La Scola B, Drancourt M, et al. (2010) MALDI-TOF-mass spectrometry applications in clinical microbiology. Future Microbiol 5: 1733-1754.
31. Falkow S (2004) Molecular Koch's postulates applied to bacterial pathogenicity-a personal recollection 15 years later. Nat Rev Microbiol 2: 67-72.
32. He Z, Kisla D, Zhang L, Yuan C, Green-Church KB, et al. (2007) Isolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin. Appl Environ Microbiol 73: 168-178. (Pubitemid 46079948)